Zero-homogeneous and O(2)-equivariant critical points of the Oseen-Frank energy with multiple Frank constants
 Nguyen, L
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
 Hetherington, S Hughes, A Mosteller, M Shortino, D Baker, K Spreen, W Lai, E Davies, K Handley, A Dow, D Fling, M Stocum, M Bowman, C Thurmond, L Roses, A Lancet (London, England) volume 359 issue 9312 1121-1122 (Mar 2002)
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programme.
 Whitehead, J Kelly, P Zhou, Y Stallard, N Thygesen, H Bowman, C Pharmaceutical statistics volume 8 issue 4 287-300 (Oct 2009)
Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
 Ramirez, C Bowman, C Maurage, C Dubois, F Blond, S Porchet, N Escande, F Neuro-oncology volume 12 issue 5 490-499 (14 May 2010)
Medical applications of haplotype-based SNP maps: learning to walk before we run.
 Lai, E Bowman, C Bansal, A Hughes, A Mosteller, M Roses, A Nature genetics volume 32 issue 3 353 (Nov 2002)
Sequentially testing for a gene-drug interaction in a genomewide analysis.
 Kelly, P Zhou, Y Whitehead, J Stallard, N Bowman, C Statistics in medicine volume 27 issue 11 2022-2034 (May 2008)
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugs.
 Kelly, P Stallard, N Zhou, Y Whitehead, J Bowman, C Statistics in medicine volume 25 issue 18 3081-3092 (Sep 2006)
Determining an adaptive exclusion procedure following discovery of an association between the whole genome and adverse drug reactions
 Su, T Thygesen, H Whitehead, J Bowman, C Drug Information Journal volume 44 issue 2 147-157 (01 Jan 2010)
Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactions.
 Thygesen, H Su, T Whitehead, J Bowman, C Journal of biopharmaceutical statistics volume 21 issue 1 111-124 (Jan 2011)
Visualizing gene determinants of disease in drug discovery.
 Delrieu, O Bowman, C Pharmacogenomics volume 7 issue 3 311-329 (Apr 2006)
Subscribe to